All ResourcesNews Fda approves wezlana as an interchangeable biosimilar to stelara for Multiple Inflammatory Diseases The US Food and Drug Administration (FDA) has approved Wezlana (ustekinumab-auub) as…Invimeds HealthNovember 2, 2023